2018-2023 Global Immuno-oncology Drugs Consumption Market Report

August 2018 | 184 pages | ID: 2F5D8F28D2FEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Immuno-oncology Drugs market for 2018-2023.

Over the next five years, LPI(LP Information) projects that Immuno-oncology Drugs will register a 14.2% CAGR in terms of revenue, reach US$ 109200 million by 2023, from US$ 49200 million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Immuno-oncology Drugs market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

• Immune Checkpoint Inhibitors
• Monoclonal Antibodies
• Cytokine-Based Immunotherapy
• Cancer Vaccines
• CAR-T Cell Therapy

Segmentation by application:

• Hospitals
• Pharmacies
• Online Pharmacies

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

• Amgen, Inc
• AstraZeneca, Plc
• Bristol-Myers Squibb
• Celgene Corporation
• Eli Lilly and Company
• Merck & Co.
• Hoffmann-La Roche AG
• Johnson & Johnson
• Novartis International AG
• AbbVie, Inc.
• Pfizer Inc.
• Sanofi S.A.
• EMD Serono, Inc.
• Gilead Sciences Inc.
• Prometheus Therapeutics & Diagnostics
• Aduro BioTech
• Galena Biopharma
• Bavarian Nordic
• Celldex Therapeutics
• ImmunoCellular Therapeutics
• Incyte

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

RESEARCH OBJECTIVES

• To study and analyze the global Immuno-oncology Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Immuno-oncology Drugs market by identifying its various subsegments.
• Focuses on the key global Immuno-oncology Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Immuno-oncology Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Immuno-oncology Drugs submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

2018-2023 GLOBAL IMMUNO-ONCOLOGY DRUGS CONSUMPTION MARKET REPORT

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Immuno-oncology Drugs Consumption 2013-2023
  2.1.2 Immuno-oncology Drugs Consumption CAGR by Region
2.2 Immuno-oncology Drugs Segment by Type
  2.2.1 Immune Checkpoint Inhibitors
  2.2.2 Monoclonal Antibodies
  2.2.3 Cytokine-Based Immunotherapy
  2.2.4 Cancer Vaccines
  2.2.5 CAR-T Cell Therapy
2.3 Immuno-oncology Drugs Consumption by Type
  2.3.1 Global Immuno-oncology Drugs Consumption Market Share by Type (2013-2018)
  2.3.2 Global Immuno-oncology Drugs Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Immuno-oncology Drugs Sale Price by Type (2013-2018)
2.4 Immuno-oncology Drugs Segment by Application
  2.4.1 Hospitals
  2.4.2 Pharmacies
  2.4.3 Online Pharmacies
2.5 Immuno-oncology Drugs Consumption by Application
  2.5.1 Global Immuno-oncology Drugs Consumption Market Share by Application (2013-2018)
  2.5.2 Global Immuno-oncology Drugs Value and Market Share by Application (2013-2018)
  2.5.3 Global Immuno-oncology Drugs Sale Price by Application (2013-2018)

3 GLOBAL IMMUNO-ONCOLOGY DRUGS BY PLAYERS

3.1 Global Immuno-oncology Drugs Sales Market Share by Players
  3.1.1 Global Immuno-oncology Drugs Sales by Players (2016-2018)
  3.1.2 Global Immuno-oncology Drugs Sales Market Share by Players (2016-2018)
3.2 Global Immuno-oncology Drugs Revenue Market Share by Players
  3.2.1 Global Immuno-oncology Drugs Revenue by Players (2016-2018)
  3.2.2 Global Immuno-oncology Drugs Revenue Market Share by Players (2016-2018)
3.3 Global Immuno-oncology Drugs Sale Price by Players
3.4 Global Immuno-oncology Drugs Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Immuno-oncology Drugs Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Immuno-oncology Drugs Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 IMMUNO-ONCOLOGY DRUGS BY REGIONS

4.1 Immuno-oncology Drugs by Regions
  4.1.1 Global Immuno-oncology Drugs Consumption by Regions
  4.1.2 Global Immuno-oncology Drugs Value by Regions
4.2 Americas Immuno-oncology Drugs Consumption Growth
4.3 APAC Immuno-oncology Drugs Consumption Growth
4.4 Europe Immuno-oncology Drugs Consumption Growth
4.5 Middle East & Africa Immuno-oncology Drugs Consumption Growth

5 AMERICAS

5.1 Americas Immuno-oncology Drugs Consumption by Countries
  5.1.1 Americas Immuno-oncology Drugs Consumption by Countries (2013-2018)
  5.1.2 Americas Immuno-oncology Drugs Value by Countries (2013-2018)
5.2 Americas Immuno-oncology Drugs Consumption by Type
5.3 Americas Immuno-oncology Drugs Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Immuno-oncology Drugs Consumption by Countries
  6.1.1 APAC Immuno-oncology Drugs Consumption by Countries (2013-2018)
  6.1.2 APAC Immuno-oncology Drugs Value by Countries (2013-2018)
6.2 APAC Immuno-oncology Drugs Consumption by Type
6.3 APAC Immuno-oncology Drugs Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Immuno-oncology Drugs by Countries
  7.1.1 Europe Immuno-oncology Drugs Consumption by Countries (2013-2018)
  7.1.2 Europe Immuno-oncology Drugs Value by Countries (2013-2018)
7.2 Europe Immuno-oncology Drugs Consumption by Type
7.3 Europe Immuno-oncology Drugs Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Immuno-oncology Drugs by Countries
  8.1.1 Middle East & Africa Immuno-oncology Drugs Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Immuno-oncology Drugs Value by Countries (2013-2018)
8.2 Middle East & Africa Immuno-oncology Drugs Consumption by Type
8.3 Middle East & Africa Immuno-oncology Drugs Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Immuno-oncology Drugs Distributors
10.3 Immuno-oncology Drugs Customer

11 GLOBAL IMMUNO-ONCOLOGY DRUGS MARKET FORECAST

11.1 Global Immuno-oncology Drugs Consumption Forecast (2018-2023)
11.2 Global Immuno-oncology Drugs Forecast by Regions
  11.2.1 Global Immuno-oncology Drugs Forecast by Regions (2018-2023)
  11.2.2 Global Immuno-oncology Drugs Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Immuno-oncology Drugs Forecast by Type
11.8 Global Immuno-oncology Drugs Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 Amgen, Inc
  12.1.1 Company Details
  12.1.2 Immuno-oncology Drugs Product Offered
  12.1.3 Amgen, Inc Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 Amgen, Inc News
12.2 AstraZeneca, Plc
  12.2.1 Company Details
  12.2.2 Immuno-oncology Drugs Product Offered
  12.2.3 AstraZeneca, Plc Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 AstraZeneca, Plc News
12.3 Bristol-Myers Squibb
  12.3.1 Company Details
  12.3.2 Immuno-oncology Drugs Product Offered
  12.3.3 Bristol-Myers Squibb Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 Bristol-Myers Squibb News
12.4 Celgene Corporation
  12.4.1 Company Details
  12.4.2 Immuno-oncology Drugs Product Offered
  12.4.3 Celgene Corporation Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 Celgene Corporation News
12.5 Eli Lilly and Company
  12.5.1 Company Details
  12.5.2 Immuno-oncology Drugs Product Offered
  12.5.3 Eli Lilly and Company Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 Eli Lilly and Company News
12.6 Merck & Co.
  12.6.1 Company Details
  12.6.2 Immuno-oncology Drugs Product Offered
  12.6.3 Merck & Co. Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.6.4 Main Business Overview
  12.6.5 Merck & Co. News
12.7 Hoffmann-La Roche AG
  12.7.1 Company Details
  12.7.2 Immuno-oncology Drugs Product Offered
  12.7.3 Hoffmann-La Roche AG Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.7.4 Main Business Overview
  12.7.5 Hoffmann-La Roche AG News
12.8 Johnson & Johnson
  12.8.1 Company Details
  12.8.2 Immuno-oncology Drugs Product Offered
  12.8.3 Johnson & Johnson Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.8.4 Main Business Overview
  12.8.5 Johnson & Johnson News
12.9 Novartis International AG
  12.9.1 Company Details
  12.9.2 Immuno-oncology Drugs Product Offered
  12.9.3 Novartis International AG Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.9.4 Main Business Overview
  12.9.5 Novartis International AG News
12.10 AbbVie, Inc.
  12.10.1 Company Details
  12.10.2 Immuno-oncology Drugs Product Offered
  12.10.3 AbbVie, Inc. Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.10.4 Main Business Overview
  12.10.5 AbbVie, Inc. News
12.11 Pfizer Inc.
12.12 Sanofi S.A.
12.13 EMD Serono, Inc.
12.14 Gilead Sciences Inc.
12.15 Prometheus Therapeutics & Diagnostics
12.16 Aduro BioTech
12.17 Galena Biopharma
12.18 Bavarian Nordic
12.19 Celldex Therapeutics
12.20 ImmunoCellular Therapeutics
12.21 Incyte

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Immuno-oncology Drugs
Table Product Specifications of Immuno-oncology Drugs
Figure Immuno-oncology Drugs Report Years Considered
Figure Market Research Methodology
Figure Global Immuno-oncology Drugs Consumption Growth Rate 2013-2023 (K Units)
Figure Global Immuno-oncology Drugs Value Growth Rate 2013-2023 ($ Millions)
Table Immuno-oncology Drugs Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Immune Checkpoint Inhibitors
Table Major Players of Immune Checkpoint Inhibitors
Figure Product Picture of Monoclonal Antibodies
Table Major Players of Monoclonal Antibodies
Figure Product Picture of Cytokine-Based Immunotherapy
Table Major Players of Cytokine-Based Immunotherapy
Figure Product Picture of Cancer Vaccines
Table Major Players of Cancer Vaccines
Figure Product Picture of CAR-T Cell Therapy
Table Major Players of CAR-T Cell Therapy
Table Global Consumption Sales by Type (2013-2018)
Table Global Immuno-oncology Drugs Consumption Market Share by Type (2013-2018)
Figure Global Immuno-oncology Drugs Consumption Market Share by Type (2013-2018)
Table Global Immuno-oncology Drugs Revenue by Type (2013-2018) ($ million)
Table Global Immuno-oncology Drugs Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Immuno-oncology Drugs Value Market Share by Type (2013-2018)
Table Global Immuno-oncology Drugs Sale Price by Type (2013-2018)
Figure Immuno-oncology Drugs Consumed in Hospitals
Figure Global Immuno-oncology Drugs Market: Hospitals (2013-2018) (K Units)
Figure Global Immuno-oncology Drugs Market: Hospitals (2013-2018) ($ Millions)
Figure Global Hospitals YoY Growth ($ Millions)
Figure Immuno-oncology Drugs Consumed in Pharmacies
Figure Global Immuno-oncology Drugs Market: Pharmacies (2013-2018) (K Units)
Figure Global Immuno-oncology Drugs Market: Pharmacies (2013-2018) ($ Millions)
Figure Global Pharmacies YoY Growth ($ Millions)
Figure Immuno-oncology Drugs Consumed in Online Pharmacies
Figure Global Immuno-oncology Drugs Market: Online Pharmacies (2013-2018) (K Units)
Figure Global Immuno-oncology Drugs Market: Online Pharmacies (2013-2018) ($ Millions)
Figure Global Online Pharmacies YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Immuno-oncology Drugs Consumption Market Share by Application (2013-2018)
Figure Global Immuno-oncology Drugs Consumption Market Share by Application (2013-2018)
Table Global Immuno-oncology Drugs Value by Application (2013-2018)
Table Global Immuno-oncology Drugs Value Market Share by Application (2013-2018)
Figure Global Immuno-oncology Drugs Value Market Share by Application (2013-2018)
Table Global Immuno-oncology Drugs Sale Price by Application (2013-2018)
Table Global Immuno-oncology Drugs Sales by Players (2016-2018) (K Units)
Table Global Immuno-oncology Drugs Sales Market Share by Players (2016-2018)
Figure Global Immuno-oncology Drugs Sales Market Share by Players in 2016
Figure Global Immuno-oncology Drugs Sales Market Share by Players in 2017
Table Global Immuno-oncology Drugs Revenue by Players (2016-2018) ($ Millions)
Table Global Immuno-oncology Drugs Revenue Market Share by Players (2016-2018)
Figure Global Immuno-oncology Drugs Revenue Market Share by Players in 2016
Figure Global Immuno-oncology Drugs Revenue Market Share by Players in 2017
Table Global Immuno-oncology Drugs Sale Price by Players (2016-2018)
Figure Global Immuno-oncology Drugs Sale Price by Players in 2017
Table Global Immuno-oncology Drugs Manufacturing Base Distribution and Sales Area by Players
Table Players Immuno-oncology Drugs Products Offered
Table Immuno-oncology Drugs Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Immuno-oncology Drugs Consumption by Regions 2013-2018 (K Units)
Table Global Immuno-oncology Drugs Consumption Market Share by Regions 2013-2018
Figure Global Immuno-oncology Drugs Consumption Market Share by Regions 2013-2018
Table Global Immuno-oncology Drugs Value by Regions 2013-2018 ($ Millions)
Table Global Immuno-oncology Drugs Value Market Share by Regions 2013-2018
Figure Global Immuno-oncology Drugs Value Market Share by Regions 2013-2018
Figure Americas Immuno-oncology Drugs Consumption 2013-2018 (K Units)
Figure Americas Immuno-oncology Drugs Value 2013-2018 ($ Millions)
Figure APAC Immuno-oncology Drugs Consumption 2013-2018 (K Units)
Figure APAC Immuno-oncology Drugs Value 2013-2018 ($ Millions)
Figure Europe Immuno-oncology Drugs Consumption 2013-2018 (K Units)
Figure Europe Immuno-oncology Drugs Value 2013-2018 ($ Millions)
Figure Middle East & Africa Immuno-oncology Drugs Consumption 2013-2018 (K Units)
Figure Middle East & Africa Immuno-oncology Drugs Value 2013-2018 ($ Millions)
Table Americas Immuno-oncology Drugs Consumption by Countries (2013-2018) (K Units)
Table Americas Immuno-oncology Drugs Consumption Market Share by Countries (2013-2018)
Figure Americas Immuno-oncology Drugs Consumption Market Share by Countries in 2017
Table Americas Immuno-oncology Drugs Value by Countries (2013-2018) ($ Millions)
Table Americas Immuno-oncology Drugs Value Market Share by Countries (2013-2018)
Figure Americas Immuno-oncology Drugs Value Market Share by Countries in 2017
Table Americas Immuno-oncology Drugs Consumption by Type (2013-2018) (K Units)
Table Americas Immuno-oncology Drugs Consumption Market Share by Type (2013-2018)
Figure Americas Immuno-oncology Drugs Consumption Market Share by Type in 2017
Table Americas Immuno-oncology Drugs Consumption by Application (2013-2018) (K Units)
Table Americas Immuno-oncology Drugs Consumption Market Share by Application (2013-2018)
Figure Americas Immuno-oncology Drugs Consumption Market Share by Application in 2017
Figure United States Immuno-oncology Drugs Consumption Growth 2013-2018 (K Units)
Figure United States Immuno-oncology Drugs Value Growth 2013-2018 ($ Millions)
Figure Canada Immuno-oncology Drugs Consumption Growth 2013-2018 (K Units)
Figure Canada Immuno-oncology Drugs Value Growth 2013-2018 ($ Millions)
Figure Mexico Immuno-oncology Drugs Consumption Growth 2013-2018 (K Units)
Figure Mexico Immuno-oncology Drugs Value Growth 2013-2018 ($ Millions)
Table APAC Immuno-oncology Drugs Consumption by Countries (2013-2018) (K Units)
Table APAC Immuno-oncology Drugs Consumption Market Share by Countries (2013-2018)
Figure APAC Immuno-oncology Drugs Consumption Market Share by Countries in 2017
Table APAC Immuno-oncology Drugs Value by Countries (2013-2018) ($ Millions)
Table APAC Immuno-oncology Drugs Value Market Share by Countries (2013-2018)
Figure APAC Immuno-oncology Drugs Value Market Share by Countries in 2017
Table APAC Immuno-oncology Drugs Consumption by Type (2013-2018) (K Units)
Table APAC Immuno-oncology Drugs Consumption Market Share by Type (2013-2018)
Figure APAC Immuno-oncology Drugs Consumption Market Share by Type in 2017
Table APAC Immuno-oncology Drugs Consumption by Application (2013-2018) (K Units)
Table APAC Immuno-oncology Drugs Consumption Market Share by Application (2013-2018)
Figure APAC Immuno-oncology Drugs Consumption Market Share by Application in 2017
Figure China Immuno-oncology Drugs Consumption Growth 2013-2018 (K Units)
Figure China Immuno-oncology Drugs Value Growth 2013-2018 ($ Millions)
Figure Japan Immuno-oncology Drugs Consumption Growth 2013-2018 (K Units)
Figure Japan Immuno-oncology Drugs Value Growth 2013-2018 ($ Millions)
Figure Korea Immuno-oncology Drugs Consumption Growth 2013-2018 (K Units)
Figure Korea Immuno-oncology Drugs Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Immuno-oncology Drugs Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia Immuno-oncology Drugs Value Growth 2013-2018 ($ Millions)
Figure India Immuno-oncology Drugs Consumption Growth 2013-2018 (K Units)
Figure India Immuno-oncology Drugs Value Growth 2013-2018 ($ Millions)
Figure Australia Immuno-oncology Drugs Consumption Growth 2013-2018 (K Units)
Figure Australia Immuno-oncology Drugs Value Growth 2013-2018 ($ Millions)
Table Europe Immuno-oncology Drugs Consumption by Countries (2013-2018) (K Units)
Table Europe Immuno-oncology Drugs Consumption Market Share by Countries (2013-2018)
Figure Europe Immuno-oncology Drugs Consumption Market Share by Countries in 2017
Table Europe Immuno-oncology Drugs Value by Countries (2013-2018) ($ Millions)
Table Europe Immuno-oncology Drugs Value Market Share by Countries (2013-2018)
Figure Europe Immuno-oncology Drugs Value Market Share by Countries in 2017
Table Europe Immuno-oncology Drugs Consumption by Type (2013-2018) (K Units)
Table Europe Immuno-oncology Drugs Consumption Market Share by Type (2013-2018)
Figure Europe Immuno-oncology Drugs Consumption Market Share by Type in 2017
Table Europe Immuno-oncology Drugs Consumption by Application (2013-2018) (K Units)
Table Europe Immuno-oncology Drugs Consumption Market Share by Application (2013-2018)
Figure Europe Immuno-oncology Drugs Consumption Market Share by Application in 2017
Figure Germany Immuno-oncology Drugs Consumption Growth 2013-2018 (K Units)
Figure Germany Immuno-oncology Drugs Value Growth 2013-2018 ($ Millions)
Figure France Immuno-oncology Drugs Consumption Growth 2013-2018 (K Units)
Figure France Immuno-oncology Drugs Value Growth 2013-2018 ($ Millions)
Figure UK Immuno-oncology Drugs Consumption Growth 2013-2018 (K Units)
Figure UK Immuno-oncology Drugs Value Growth 2013-2018 ($ Millions)
Figure Italy Immuno-oncology Drugs Consumption Growth 2013-2018 (K Units)
Figure Italy Immuno-oncology Drugs Value Growth 2013-2018 ($ Millions)
Figure Russia Immuno-oncology Drugs Consumption Growth 2013-2018 (K Units)
Figure Russia Immuno-oncology Drugs Value Growth 2013-2018 ($ Millions)
Figure Spain Immuno-oncology Drugs Consumption Growth 2013-2018 (K Units)
Figure Spain Immuno-oncology Drugs Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Immuno-oncology Drugs Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa Immuno-oncology Drugs Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Immuno-oncology Drugs Consumption Market Share by Countries in 2017
Table Middle East & Africa Immuno-oncology Drugs Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Immuno-oncology Drugs Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Immuno-oncology Drugs Value Market Share by Countries in 2017
Table Middle East & Africa Immuno-oncology Drugs Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa Immuno-oncology Drugs Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Immuno-oncology Drugs Consumption Market Share by Type in 2017
Table Middle East & Africa Immuno-oncology Drugs Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa Immuno-oncology Drugs Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Immuno-oncology Drugs Consumption Market Share by Application in 2017
Figure Egypt Immuno-oncology Drugs Consumption Growth 2013-2018 (K Units)
Figure Egypt Immuno-oncology Drugs Value Growth 2013-2018 ($ Millions)
Figure South Africa Immuno-oncology Drugs Consumption Growth 2013-2018 (K Units)
Figure South Africa Immuno-oncology Drugs Value Growth 2013-2018 ($ Millions)
Figure Israel Immuno-oncology Drugs Consumption Growth 2013-2018 (K Units)
Figure Israel Immuno-oncology Drugs Value Growth 2013-2018 ($ Millions)
Figure Turkey Immuno-oncology Drugs Consumption Growth 2013-2018 (K Units)
Figure Turkey Immuno-oncology Drugs Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Immuno-oncology Drugs Consumption Growth 2013-2018 (K Units)
Figure GCC Countries Immuno-oncology Drugs Value Growth 2013-2018 ($ Millions)
Table Immuno-oncology Drugs Distributors List
Table Immuno-oncology Drugs Customer List
Figure Global Immuno-oncology Drugs Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global Immuno-oncology Drugs Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Immuno-oncology Drugs Consumption Forecast by Countries (2018-2023) (K Units)
Table Global Immuno-oncology Drugs Consumption Market Forecast by Regions
Table Global Immuno-oncology Drugs Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Immuno-oncology Drugs Value Market Share Forecast by Regions
Figure Americas Immuno-oncology Drugs Consumption 2018-2023 (K Units)
Figure Americas Immuno-oncology Drugs Value 2018-2023 ($ Millions)
Figure APAC Immuno-oncology Drugs Consumption 2018-2023 (K Units)
Figure APAC Immuno-oncology Drugs Value 2018-2023 ($ Millions)
Figure Europe Immuno-oncology Drugs Consumption 2018-2023 (K Units)
Figure Europe Immuno-oncology Drugs Value 2018-2023 ($ Millions)
Figure Middle East & Africa Immuno-oncology Drugs Consumption 2018-2023 (K Units)
Figure Middle East & Africa Immuno-oncology Drugs Value 2018-2023 ($ Millions)
Figure United States Immuno-oncology Drugs Consumption 2018-2023 (K Units)
Figure United States Immuno-oncology Drugs Value 2018-2023 ($ Millions)
Figure Canada Immuno-oncology Drugs Consumption 2018-2023 (K Units)
Figure Canada Immuno-oncology Drugs Value 2018-2023 ($ Millions)
Figure Mexico Immuno-oncology Drugs Consumption 2018-2023 (K Units)
Figure Mexico Immuno-oncology Drugs Value 2018-2023 ($ Millions)
Figure Brazil Immuno-oncology Drugs Consumption 2018-2023 (K Units)
Figure Brazil Immuno-oncology Drugs Value 2018-2023 ($ Millions)
Figure China Immuno-oncology Drugs Consumption 2018-2023 (K Units)
Figure China Immuno-oncology Drugs Value 2018-2023 ($ Millions)
Figure Japan Immuno-oncology Drugs Consumption 2018-2023 (K Units)
Figure Japan Immuno-oncology Drugs Value 2018-2023 ($ Millions)
Figure Korea Immuno-oncology Drugs Consumption 2018-2023 (K Units)
Figure Korea Immuno-oncology Drugs Value 2018-2023 ($ Millions)
Figure Southeast Asia Immuno-oncology Drugs Consumption 2018-2023 (K Units)
Figure Southeast Asia Immuno-oncology Drugs Value 2018-2023 ($ Millions)
Figure India Immuno-oncology Drugs Consumption 2018-2023 (K Units)
Figure India Immuno-oncology Drugs Value 2018-2023 ($ Millions)
Figure Australia Immuno-oncology Drugs Consumption 2018-2023 (K Units)
Figure Australia Immuno-oncology Drugs Value 2018-2023 ($ Millions)
Figure Germany Immuno-oncology Drugs Consumption 2018-2023 (K Units)
Figure Germany Immuno-oncology Drugs Value 2018-2023 ($ Millions)
Figure France Immuno-oncology Drugs Consumption 2018-2023 (K Units)
Figure France Immuno-oncology Drugs Value 2018-2023 ($ Millions)
Figure UK Immuno-oncology Drugs Consumption 2018-2023 (K Units)
Figure UK Immuno-oncology Drugs Value 2018-2023 ($ Millions)
Figure Italy Immuno-oncology Drugs Consumption 2018-2023 (K Units)
Figure Italy Immuno-oncology Drugs Value 2018-2023 ($ Millions)
Figure Russia Immuno-oncology Drugs Consumption 2018-2023 (K Units)
Figure Russia Immuno-oncology Drugs Value 2018-2023 ($ Millions)
Figure Spain Immuno-oncology Drugs Consumption 2018-2023 (K Units)
Figure Spain Immuno-oncology Drugs Value 2018-2023 ($ Millions)
Figure Egypt Immuno-oncology Drugs Consumption 2018-2023 (K Units)
Figure Egypt Immuno-oncology Drugs Value 2018-2023 ($ Millions)
Figure South Africa Immuno-oncology Drugs Consumption 2018-2023 (K Units)
Figure South Africa Immuno-oncology Drugs Value 2018-2023 ($ Millions)
Figure Israel Immuno-oncology Drugs Consumption 2018-2023 (K Units)
Figure Israel Immuno-oncology Drugs Value 2018-2023 ($ Millions)
Figure Turkey Immuno-oncology Drugs Consumption 2018-2023 (K Units)
Figure Turkey Immuno-oncology Drugs Value 2018-2023 ($ Millions)
Figure GCC Countries Immuno-oncology Drugs Consumption 2018-2023 (K Units)
Figure GCC Countries Immuno-oncology Drugs Value 2018-2023 ($ Millions)
Table Global Immuno-oncology Drugs Consumption Forecast by Type (2018-2023) (K Units)
Table Global Immuno-oncology Drugs Consumption Market Share Forecast by Type (2018-2023)
Table Global Immuno-oncology Drugs Value Forecast by Type (2018-2023) ($ Millions)
Table Global Immuno-oncology Drugs Value Market Share Forecast by Type (2018-2023)
Table Global Immuno-oncology Drugs Consumption Forecast by Application (2018-2023) (K Units)
Table Global Immuno-oncology Drugs Consumption Market Share Forecast by Application (2018-2023)
Table Global Immuno-oncology Drugs Value Forecast by Application (2018-2023) ($ Millions)
Table Global Immuno-oncology Drugs Value Market Share Forecast by Application (2018-2023)
Table Amgen, Inc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Amgen, Inc Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Amgen, Inc Immuno-oncology Drugs Market Share (2016-2018)
Table AstraZeneca, Plc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca, Plc Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure AstraZeneca, Plc Immuno-oncology Drugs Market Share (2016-2018)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bristol-Myers Squibb Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Bristol-Myers Squibb Immuno-oncology Drugs Market Share (2016-2018)
Table Celgene Corporation Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Celgene Corporation Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Celgene Corporation Immuno-oncology Drugs Market Share (2016-2018)
Table Eli Lilly and Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly and Company Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Eli Lilly and Company Immuno-oncology Drugs Market Share (2016-2018)
Table Merck & Co. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck & Co. Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Merck & Co. Immuno-oncology Drugs Market Share (2016-2018)
Table Hoffmann-La Roche AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Hoffmann-La Roche AG Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Hoffmann-La Roche AG Immuno-oncology Drugs Market Share (2016-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Johnson & Johnson Immuno-oncology Drugs Market Share (2016-2018)
Table Novartis International AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis International AG Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Novartis International AG Immuno-oncology Drugs Market Share (2016-2018)
Table AbbVie, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AbbVie, Inc. Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure AbbVie, Inc. Immuno-oncology Drugs Market Share (2016-2018)
Table Pfizer Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi S.A. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table EMD Serono, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Gilead Sciences Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Prometheus Therapeutics & Diagnostics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Aduro BioTech Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Galena Biopharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bavarian Nordic Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Celldex Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table ImmunoCellular Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Incyte Basic Information, Manufacturing Base, Sales Area and Its Competitors